Zobrazeno 1 - 10
of 46
pro vyhledávání: '"István, Czuriga"'
Autor:
Mária Lódi, Viktor Bánhegyi, Beáta Bódi, Alexandra Gyöngyösi, Árpád Kovács, Anita Árokszállási, Nazha Hamdani, Miklós Fagyas, István Édes, Zoltán Csanádi, István Czuriga, Zoltán Kisvárday, István Lekli, Péter Bai, Attila Tóth, Zoltán Papp, Dániel Czuriga
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-18 (2020)
Abstract Background Cardiomyopathy is a common side effect of doxorubicin (DOX) chemotherapy. Despite intensive research efforts in the field, there is still no evidence available for routine cardioprotective prophylaxis to prevent cardiotoxicity in
Externí odkaz:
https://doaj.org/article/2ac15617c7aa42b2999a5adb53714ca2
Autor:
Mária Lódi, Dániel Priksz, Gábor Áron Fülöp, Beáta Bódi, Alexandra Gyöngyösi, Lilla Nagy, Árpád Kovács, Attila Béla Kertész, Judit Kocsis, István Édes, Zoltán Csanádi, István Czuriga, Zoltán Kisvárday, Béla Juhász, István Lekli, Péter Bai, Attila Tóth, Zoltán Papp, Dániel Czuriga
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-16 (2019)
Abstract Background Chemotherapy-induced left ventricular dysfunction represents a major clinical problem, which is often only recognised at an advanced stage, when supportive therapy is ineffective. Although an early heart failure treatment could po
Externí odkaz:
https://doaj.org/article/8267468ab3be437ba254b9563f758148
Publikováno v:
Haematologica, Vol 92, Iss 2 (2007)
Factor XIII (FXIII) activity and antigen levels were determined in 955 patients investigated by coronary angiography. Patients were sub-grouped according to the presence or absence of coronary sclerosis (CS+, CS−) and a positive history of myocardi
Externí odkaz:
https://doaj.org/article/cd02533e6f49405fa747f87ae1907879
Autor:
Dániel Czuriga, Balázs Sármán, Mária Lódi, István Czuriga, Petra Gulácsi-Bárdos, András Nagy, Miklós Szokol, István Édes
Publikováno v:
Orvosi Hetilap. 158:1691-1697
Abstract: Cardiovascular and oncologic diseases are the causes of more than 50 percent of mortality in Europe. In 2015 oncologic and cardiovascular mortality reached 70 percent in Hungary. Patients who receive anticancer therapies are at a 2- to 7-fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::890c41846638fb0da6be151de7acc0ff
https://doi.org/10.1556/650.2017.30897
https://doi.org/10.1556/650.2017.30897
Autor:
Éva Katona, Szilvia Fiatal, Róza Ádány, Zoltán András Mezei, István Édes, István Czuriga, Emilia Balogh, Réka Gindele, Zsuzsanna Bereczky, László Muszbek, László Balogh
Publikováno v:
International Journal of Molecular Sciences, Vol 16, Iss 1, Pp 1143-1159 (2015)
International Journal of Molecular Sciences
Volume 16
Issue 1
Pages 1143-1159
International Journal of Molecular Sciences
Volume 16
Issue 1
Pages 1143-1159
The aim of the case-control study was to explore the effect of coagulation factor XIII (FXIII) B subunit (FXIII-B) polymorphisms on the risk of coronary artery disease, and on FXIII levels. In the study, 687 patients admitted for coronary angiography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b59b2463f89c4b6b09afb0a4b9782fa1
http://www.mdpi.com/1422-0067/16/1/1143
http://www.mdpi.com/1422-0067/16/1/1143
Autor:
Petra, Gulácsi-Bárdos, Miklós, Szokol, Mária, Lódi, Dániel, Czuriga, István, Czuriga, István, Édes, András, Nagy, Balázs, Sármán
Publikováno v:
Orvosi hetilap. 158(43)
Cardiovascular and oncologic diseases are the causes of more than 50 percent of mortality in Europe. In 2015 oncologic and cardiovascular mortality reached 70 percent in Hungary. Patients who receive anticancer therapies are at a 2- to 7-fold greater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ae33d586361df4823f938a4225592985
https://pubmed.ncbi.nlm.nih.gov/29135296
https://pubmed.ncbi.nlm.nih.gov/29135296
Autor:
Dániel Czuriga, Judit Kocsis, Zoltán F. Kisvárday, I. Édes, Dániel Priksz, Bela Juhasz, István Czuriga, Gabor A. Fulop, Attila Tóth, Mária Lódi, Zoltán Papp
Publikováno v:
European Heart Journal. 38
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::82ebaf0030c042a78468ca2f1579ba5f
https://doi.org/10.1093/eurheartj/ehx504.p4356
https://doi.org/10.1093/eurheartj/ehx504.p4356
Publikováno v:
Orvosi Hetilap. 153:2030-2040
Diastolic heart failure, which is also called as heart failure with preserved ejection fraction, is a clinical syndrome in which patients have signs and symptoms of heart failure, normal or near normal left ventricular ejection fraction (≥50%) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5119057dfd78412063d8a38ab1f2368
https://doi.org/10.1556/oh.2012.29506
https://doi.org/10.1556/oh.2012.29506
Autor:
István, Czuriga
Publikováno v:
Orvosi hetilap. 157(38)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d908b909baec634df570061269e2440
https://pubmed.ncbi.nlm.nih.gov/27640614
https://pubmed.ncbi.nlm.nih.gov/27640614
Autor:
Attila Kertész, Andrea Péter, László Fülöp, Annamária Bódi, Dániel Czuriga, István Édes, Ferenc Győry, Andrea Szegedi, Sándor Sipka, Attila Szilágyi, István Czuriga
QT interval prolongation on the electrocardiogram is considered a precursory sign for imminent, potentially lethal ventricular arrhythmias. Beside the inherited condition of long QT syndrome, numerous drugs, certain electrolyte disturbances and early
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a430ce3a49c231f643be24b13682be2
